A few months after raising $128 million in an upsized initial public offering, Massachusetts-based biotechnology company Finch Therapeutics, Inc., is expanding in Boston by leasing additional space near its existing office at 200 Inner Belt Road in Sommerville.
Finch Therapeutics Expands Boston-Area Office After Recent IPO
Microbiome Therapeutics Company Signs 10-Year Office Lease in Hood Park Redevelopment in Charlestown
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Hood Park
100 Hood Park Dr, Charlestown, MA
- Companies
- Finch Therapeutics, Inc.
Manufacturing
- Contacts
- Debra Gould
Executive Managing Director, Newmark
- Tim Bianchi
Executive Managing Director, Newmark
- Nicole Kelley
Senior Transaction Services Specialist